TarakcE, Arman N, TarakcD, Kasapcopur O. Leap Motn Controller-based trag for upper extremy rehabatn chdren and adolescents wh physal dabs: A randomed controlled trl. J Hand Ther. 2020 Apr-Jun;33(2):220-228.e1. do 10.1016/j.jht.2019.03.012. Epub 2019 Apr 19. Murphy SL, Poole JL, Chen YT, Lescoat A, Khanna D. Rehabatn terventns System Scleros: A Systemat Revw and Future Dectns. Arthr Care Res (Hoboken). 2022 Jan;74(1):59-69. do 10.1002/acr.24737. Epub 2021 Dec 22. The Development and Investigation of Effectiveness of Leap Motion Based Gamefication Exercises in Hand Rehabilitation of the Individuals With Systemic Sclerosis
Mouthon L, Rannou F, Berezne A, Pagnoux C, Arene JP, Fo E, Cabane J, Gulev L, Revel M, Fermann J, Poaudeau S. Development and valatn of a scale for mouth handap system scleros: the Mouth Handap System Scleros scale. Ann Rheum D. 2007 Dec;66(12):1651-5. do 10.1136/ard.2007.070532. Epub 2007 May 14. MaddalBongS, Del Rosso A, Mt Gallucc F, LandG, TaG, MatuccCer M. The aln versn of the Mouth Handap System Scleros scale (MHS) val, relble and useful assessg oral health-related qualy of le (OHRQoL) system scleros (SSc) patnts. Rheumatol t. 2012 Sep;32(9):2785-90. do 10.1007/s00296-011-2049-x. Epub 2011 Aug 17. Schouffoer AA, Strbos E, Schuerwegh AJ, Mouthon L, Vlt Vlland TP. Translatn, cross-cultural adaptatn, and valatn of the Mouth Handap System Scleros questnnae (MHS) to the Dutch language. Cl Rheumatol. 2013 Nov;32(11):1649-55. do 10.1007/s10067-013-2321-4. Epub 2013 Jul 24. Scarda GA, Messa P. System scleros: descrtn and dgnost role of the oral phenomena. Gen Dent. 2004 Jan-Feb;52(1):42-7. Naylor WP, Douglass CW, M E. The nonsurgal treatment of mrostom scleroderma: a pot study. Oral Surg Oral Med Oral Pathol. 1984 May;57(5):508-11. do 10.1016/0030-4220(84)90309-8. Mouth Handicap in Systemic Sclerosis
Dtler O, Cozz A. System scleros and localed scleroderma--current concepts and novel targets for therapy. Sem munopathol. 2016 Jan;38(1):87-95. do 10.1007/s00281-015-0551-z. Epub 2015 Nov 17. Vehe RK, Rkalla MM. Collagen Vascular Deases: SLE, Dermatomyos, Scleroderma, and MCTD. Pedtr Rev. 2018 Oct;39(10):501-515. do 10.1542/p.2017-0262. No abstract avaable. Land SF, Bertolo MB, Marcatto de Abreu MF, Del R AP, Mazon CC, Marques-Neto JF, Poole JL, de Paa Magalhaes E. The evaluatn of a home-based program for hands patnts wh system scleros. J Hand Ther. 2019 Jul-Sep;32(3):313-321. do 10.1016/j.jht.2017.10.013. Epub 2017 Dec 1. AntonlCM, Bua G, Fre A, PrandK, RadS, ScarsM, DanlE, MalvA, Ao P. An dualed rehabatn program patnts wh system scleros may prove qualy of le and hand moby. Cl Rheumatol. 2009 Feb;28(2):159-65. do 10.1007/s10067-008-1006-x. Epub 2008 Sep 16. Lopes AJ, Justo AC, Ferrea AS, Guaraes FS. System scleros: Assoctn between physal functn, handgr strength and pulmonary functn. J Bodyw Mov Ther. 2017 Oct;21(4):972-977. do 10.1016/j.jbmt.2017.03.018. Epub 2017 Mar 29. Mancuso T, Poole JL. The effect of paraff and exerce on hand functn persons wh scleroderma: a sers of sgle case studs. J Hand Ther. 2009 Jan-Mar;22(1):71-7; qu 78. do 10.1016/j.jht.2008.06.009. Epub 2008 Aug 30. Rannou F, Boutron Mouthon L, Sanchez K, Tfreau V, Hachulla E, Thoum P, Cabane J, Chatelus E, S J, Roren A, Berezne A, Baron G, Porcher R, Gulev L, Ravaud P, Poaudeau S. Personaled Physal Therapy Versus Usual Care for Patnts Wh System Scleros: A Randomed Controlled Trl. Arthr Care Res (Hoboken). 2017 Jul;69(7):1050-1059. do 10.1002/acr.23098. Epub 2017 Jun 7. Schapa AH, Holt , Sweeney M, Hardg AE, Jenner P, Marsden CD. Mochondrl DNA analys Parkson's dease. Mov Dord. 1990;5(4):294-7. do 10.1002/mds.870050406. The Effect of Physiotherapy Program in Scleroderma Patients: A Randomized Clinical Trial